New transplant strategy aims to tame deadly blood cancers
NCT ID NCT06195891
Summary
This early-stage study is testing a new type of stem cell transplant for adults aged 60-75 with acute leukemias or myelodysplastic syndrome (MDS). The approach combines a precise form of radiation targeting bone marrow and lymph nodes with chemotherapy, followed by an infusion of specially prepared donor cells called Orca-T. The main goal is to find the safest dose of radiation and see if this combined treatment can control these aggressive blood cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.